Сost of healthcare in Russia will amount to 6% of GDP by 2020 - deputy PM
28 June 2013
The pharmaceutical market in Russia - current status, trends and changes
11 June 2013
During his speech at BioForum 2013 in Budapest, Artur Shigabutdinov, from the Russian company Nadim Cro, characterized the pharmaceutical sector in Russia. He stressed the important role of generic drugs in the development of the pharmaceutical sector in the country, listed the factors stimulating development of the sector, as well as those that slow it down and talked about the changes in Russian legislation that reflect on the performance of the sector.
Government obliges corporations to buy Russian technologies
10 June 2013
The government intends to make a list of innovative products and services which share in state companies’ purchases should be increased. The priority will be given to Russian suppliers.
How to invest in Russian technoparks
10 June 2013
In the 2000s, the Russian government came to regard technoparks as a perfect means of fostering innovation in the country's economy. Technoparks began to spring up all over the country, thanks to numerous government programs and initiatives. Five years ago, a World Bank study confirmed that one of Russia’s provinces, the Republic of Tatarstan, had more technoparks per capita than the country which invented them — the United Kingdom.
EU, Russia Sign New Agreement On Combating Illicit Drugs
07 June 2013
The European Union and Russia have signed a new agreement that will strengthen cooperation between the two sides in preventing drug precursors from being trafficked for the manufacture of illegal drugs, it was announced Tuesday.
HemaCore Company’s device wins international design award
06 June 2013
Trombodynamics Analyser produced by RUSNANO’s project company HemaCore and used for the blood coagulation system diagnosis has won the Red Dot Award in the Product Design category. German company WILDDESIGN developed the instrument design by order of HemaCore Company.
Recent developments in the Russian pharmaceutical industry
06 June 2013
During the first few months of 2013, the Russian government has proposed, and in some cases adopted, new legislation that introduces a number of significant changes to the regulation of (1) the procurement of pharmaceuticals1 by Russian state-owned clinics, the Ministry of Health and other Russian federal, regional and local governmental authorities and financed from the federal, regional or municipal budgets (“Government Procurement”) and (2) the advertisement of biologically active substances and pharmaceuticals in Russia.
Russia signals for stronger bilateral relation with India in healthcare sector
06 June 2013
Russia has sent strong signal to strengthen the bilateral ties between the two countries in the healthcare sector, by inviting the Indian pharma companies and hospitals to set up their base in Russia. This was informed by the top representatives of the Russian government, during a high level interactive meeting in Mumbai recently.
06 June 2013
CPhI Russia reflected growth in the Russian Pharma market at its debut next to IPhEB, the St Petersburg International Forum for Pharmacy, Medical Equipment, Biotechnology and Radiology, and is the latest addition to UBM Live's global pharmaceutical events portfolio. The event was held in St Petersburg on April 2013 and brought together senior Russian pharma professionals and international pharmaceutical suppliers and buyers.
Russian and US scientists launch type 2 diabetes drug program
31 May 2013
Russian and US researchers have launched a joint project aimed at developing an innovation drug candidate to fight type 2 diabetes, the website of Russia’s ChemRar biotech research company announced earlier this week.
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
16 May 2024
06 September 2024
HPV vaccine is to be included in Russia’s national immunization schedule by 2026
06 September 2024
New WHO guidance to support manufacturers to reduce AMR risk
05 September 2024
05 September 2024